Page last updated: 2024-10-20

quinolinic acid and Central Nervous System Diseases

quinolinic acid has been researched along with Central Nervous System Diseases in 7 studies

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Quinolinic acid is an agonist at the population of glutamate receptors which are sensitive to N-methyl-D-aspartate (NMDA), and kynurenic acid is an antagonist at several glutamate receptors."6.42Tryptophan metabolites and brain disorders. ( Clark, CJ; Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW, 2003)
"Quinolinic acid (QUIN) is a neurotoxic metabolite of the kynurenine pathway that accumulates within the central nervous system following immune activation."5.29Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. ( Heyes, MP; Milstien, S; Saito, K; Schiff, SJ, 1995)
"Quinolinic acid is an agonist at the population of glutamate receptors which are sensitive to N-methyl-D-aspartate (NMDA), and kynurenic acid is an antagonist at several glutamate receptors."2.42Tryptophan metabolites and brain disorders. ( Clark, CJ; Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW, 2003)
"In patients with no apparent CNS disease, CSF PIC levels were 10-fold higher in samples taken between 20:00 and 16:00 h compared with those collected between 04:00 and 12:00 h."1.35Age and circadian influences on picolinic acid concentrations in human cerebrospinal fluid. ( Bilgin, A; Coggan, SE; Grant, RS; Smythe, GA, 2009)
"Quinolinic acid (QUIN) is a neurotoxic metabolite of the kynurenine pathway that accumulates within the central nervous system following immune activation."1.29Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. ( Heyes, MP; Milstien, S; Saito, K; Schiff, SJ, 1995)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costantino, G1
Coggan, SE1
Smythe, GA1
Bilgin, A1
Grant, RS1
Kandanearatchi, A1
Brew, BJ1
Stone, TW2
Mackay, GM1
Forrest, CM1
Clark, CJ1
Darlington, LG1
Heyes, MP2
Saito, K1
Milstien, S1
Schiff, SJ1
Lane, JH1
Sasseville, VG1
Smith, MO1
Vogel, P1
Pauley, DR1
Lackner, AA1

Reviews

3 reviews available for quinolinic acid and Central Nervous System Diseases

ArticleYear
The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.
    The FEBS journal, 2012, Volume: 279, Issue:8

    Topics: Central Nervous System Diseases; Cognition Disorders; HIV; HIV Infections; Humans; Kynurenine; Quino

2012
Tryptophan metabolites and brain disorders.
    Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:7

    Topics: AIDS Dementia Complex; Brain Diseases; Central Nervous System Diseases; Humans; Huntington Disease;

2003
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.
    Progress in neurobiology, 2001, Volume: 64, Issue:2

    Topics: Animals; Central Nervous System; Central Nervous System Diseases; Humans; Kynurenine; Neurotoxins; Q

2001

Other Studies

4 other studies available for quinolinic acid and Central Nervous System Diseases

ArticleYear
Inhibitors of quinolinic acid synthesis: new weapons in the study of neuroinflammatory diseases.
    Future medicinal chemistry, 2014, Volume: 6, Issue:8

    Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; Central Nervous System Diseases; Enzyme Inhibitors; Humans; K

2014
Age and circadian influences on picolinic acid concentrations in human cerebrospinal fluid.
    Journal of neurochemistry, 2009, Volume: 108, Issue:5

    Topics: Aging; Analysis of Variance; C-Reactive Protein; Case-Control Studies; Central Nervous System Diseas

2009
Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.
    Journal of the neurological sciences, 1995, Volume: 133, Issue:1-2

    Topics: Adolescent; Adult; Bacterial Infections; Biomarkers; Biopterins; Central Nervous System Diseases; Ce

1995
Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation.
    Journal of neurovirology, 1996, Volume: 2, Issue:6

    Topics: Animals; Brain; Capillaries; Central Nervous System Diseases; Cerebrovascular Circulation; DNA, Vira

1996